109 related articles for article (PubMed ID: 23269015)
1. Reduction in the vascular bed volume of uterine fibroids after hormonal treatment: evaluation with dynamic double-echo R₂* imaging.
Okuda S; Oshio K; Asada H; Tanimoto A; Jinzaki M; Furuya M; Yoshimura Y; Kuribayashi S
Magn Reson Med Sci; 2012; 11(4):283-9. PubMed ID: 23269015
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
Okuda S; Oshio K; Shinmoto H; Tanimoto A; Asada H; Fujii T; Yoshimura Y; Kuribayashi S
Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of magnetic resonance imaging signal and contrast-enhancement characteristics on post-embolization volume reduction of uterine fibroids.
Harman M; Zeteroğlu S; Arslan H; Sengül M; Etlik O
Acta Radiol; 2006 May; 47(4):427-35. PubMed ID: 16739706
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-enhanced MR imaging in the evaluation of uterine fibroids treated with uterine artery embolization.
Katsumori T; Nakajima K; Tokuhiro M
AJR Am J Roentgenol; 2001 Aug; 177(2):303-7. PubMed ID: 11461850
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids.
Park H; Yoon SW
Radiol Med; 2017 Aug; 122(8):611-616. PubMed ID: 28341966
[TBL] [Abstract][Full Text] [Related]
7. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
8. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
Adamson GD
Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
[TBL] [Abstract][Full Text] [Related]
9. Uterine fibroid tumors: long-term MR imaging outcome after embolization.
Pelage JP; Guaou NG; Jha RC; Ascher SM; Spies JB
Radiology; 2004 Mar; 230(3):803-9. PubMed ID: 14990844
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog.
Chia CC; Huang SC; Chen SS; Kang JY; Lin JC; Lin YS; Huang KF; Lee HJ; Zheng CC
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):124-8. PubMed ID: 17197352
[TBL] [Abstract][Full Text] [Related]
11. Doppler-ultrasound as a predictor of uterine fibroid response to GnRH therapy.
Kanelopoulos N; Dendrinos S; Oikonomou A; Panagopoulos P; Markussis V
Int J Gynaecol Obstet; 2003 Jul; 82(1):41-7. PubMed ID: 12834940
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus.
Zhang L; Chen WZ; Liu YJ; Hu X; Zhou K; Chen L; Peng S; Zhu H; Zou HL; Bai J; Wang ZB
Eur J Radiol; 2010 Feb; 73(2):396-403. PubMed ID: 19108974
[TBL] [Abstract][Full Text] [Related]
13. GnRH analogues in the treatment of uterine fibroids.
Golan A
Hum Reprod; 1996 Nov; 11 Suppl 3():33-41. PubMed ID: 9147100
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T
Yang S; Kong F; Hou R; Rong F; Ma N; Li S; Yang J
Br J Radiol; 2017 May; 90(1073):20160760. PubMed ID: 28256923
[TBL] [Abstract][Full Text] [Related]
15. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
Kessel B; Liu J; Mortola J; Berga S; Yen SS
Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
[TBL] [Abstract][Full Text] [Related]
16. Quantitative serial MRI of the treated fibroid uterus.
Munro KI; Thrippleton MJ; Williams AR; McKillop G; Walker J; Horne AW; Newby DE; Anderson RA; Semple SI; Marshall I; Lewis SC; Millar RP; Bastin ME; Critchley HO
PLoS One; 2014; 9(3):e89809. PubMed ID: 24608161
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of LHRH analogue action in uterine fibroids.
Shaw RW
Horm Res; 1989; 32 Suppl 1():150-3. PubMed ID: 2533145
[TBL] [Abstract][Full Text] [Related]
18. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
19. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
Khan KN; Fujishita A; Koshiba A; Ogawa K; Mori T; Ogi H; Itoh K; Teramukai S; Kitawaki J
PLoS One; 2020; 15(11):e0242246. PubMed ID: 33186388
[TBL] [Abstract][Full Text] [Related]
20. MR venography of deep veins: changes with uterine fibroid embolization.
Katsumori T; Kasahara T; Tsuchida Y; Nara Y
Cardiovasc Intervent Radiol; 2009 Mar; 32(2):284-8. PubMed ID: 19011939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
